Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel + Cisplatin vs Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03047265Phase 2Active, not recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Feb 2017
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Started Feb 2017; status: active, not recruiting.
02
Drugs
paclitaxel
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT03047265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03047265.